Kosach G A, Petrosyan A L, Yaremenko A I, Zubareva A A, Kutukova S I, Yagmurov O D, Chefu S G, Molokova V A, Ignatova V D, Kosach S A, Vlasov T D
Resident of maxillo-facial surgeon department, First Pavlov State Medical University of St. Peterburg, L'va Tolstogo str., 6-8, Saint Petersburg, Russian Federation, 197022.
First Pavlov State Medical University of St. Peterburg, L'va Tolstogo str., 6-8, Saint Petersburg, Russian Federation, 197022.
Br J Oral Maxillofac Surg. 2020 Nov;58(9):e38-e44. doi: 10.1016/j.bjoms.2020.05.030. Epub 2020 Jun 12.
We investigated the possibilities of angioprotection and the reduction of osteonecrosis in rats that had been given bisphosphonates. In our experiment, 27 rats were divided into three groups: Group 1 was injected with saline; Group 2 was given zoledronic acid for six weeks; and Group 3 was given zoledronic acid for six weeks, with added doses of sulodexide after three weeks. After that we constructed a model of how the teeth should be extracted. The velocity of linear blood flow in the periodontal area of an extracted tooth in rats was studied using laser and high-frequency Doppler ultrasound (with the application of the vasoactive substance acetylcholine 3% for 1min). We evaluated changes in the structure of the bony tissues of the head using computed tomography, comparing the control group with the saline group. A rapid reduction in microcirculation was detected during the use of zoledronic acid for six weeks. A smaller reduction in microcirculation was detected after three weeks of treatment with sulodexide and zoledronic acid. There was a reduction in blood flow in the mucous membranes and, to a greater extent, in bony tissue. Zoledronic acid causes significant impairment of the periosteal blood flow to the mucous membranes because of a complex of disorders, which includes both the cellular component (impaired endothelium-dependent vasodilation of the mucous membrane vessels) and by reducing the intensity of microcirculation in the mucous membranes and bony tissues. Sulodexide, however, improves the restoration of blood flow and reduces the severity of osteonecrosis.
我们研究了双膦酸盐给药大鼠的血管保护及减少骨坏死的可能性。在我们的实验中,27只大鼠被分为三组:第1组注射生理盐水;第2组给予唑来膦酸六周;第3组给予唑来膦酸六周,三周后追加舒洛地特剂量。之后我们构建了拔牙模型。使用激光和高频多普勒超声(应用3%血管活性物质乙酰胆碱1分钟)研究大鼠拔牙后牙周区域的线性血流速度。我们使用计算机断层扫描评估头部骨组织结构的变化,将对照组与生理盐水组进行比较。使用唑来膦酸六周期间检测到微循环迅速减少。舒洛地特和唑来膦酸治疗三周后检测到微循环减少程度较小。黏膜和骨组织中的血流均减少。唑来膦酸由于一系列紊乱,包括细胞成分(黏膜血管内皮依赖性血管舒张受损)以及黏膜和骨组织中微循环强度降低,导致黏膜骨膜血流显著受损。然而,舒洛地特可改善血流恢复并减轻骨坏死的严重程度。